catechin has been researched along with probenecid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Hara, Y; Hong, J; Lu, H; Meng, X; Ryu, JH; Yang, CS | 1 |
Anandhan, A; Essa, MM; Manivasagam, T; Radhiga, T; Rao, S; Tamilselvam, K | 1 |
Anandhan, A; Essa, MM; Manivasagam, T | 1 |
1 review(s) available for catechin and probenecid
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
5 other study(ies) available for catechin and probenecid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Catechin; Drug Stability; HT29 Cells; Humans; Hydrogen Peroxide; Indomethacin; Oxidation-Reduction; Probenecid; Temperature; Tritium; Vinblastine | 2002 |
Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biflavonoids; Catechin; Dopaminergic Neurons; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Pilot Projects; Polyphenols; Probenecid; Random Allocation; Substantia Nigra; Tea | 2012 |
Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Biflavonoids; Catechin; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dyskinesias; Encephalitis; Glial Fibrillary Acidic Protein; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Probenecid; Proto-Oncogene Proteins c-bcl-2; Reaction Time | 2013 |